Proscia to Collaborate with Columbia University on Biomarker Discovery for Neurodegenerative Diseases
recent articles
Mindpeak: Patent covers novel approach for training AI systems and classifying cells in oncologic histopathological tissue diagnostics Hamburg, Germany – 10 December 2025 – Mindpeak, a global pioneer in AI-powered pathology solutions,...
Proscia: Delivering high-throughput results with speed and precision NEW YORK and PHILADELPHIA – December 9, 2025 – New York Gastroenterology Associates, LLP (NYGA), New York City’s leading independent gastroenterology practice, is...
VISTA, California, December 9, 2025 – Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold step forward in the digital transformation of...
A woman underwent a total hysterectomy at Penn based on a cancer misdiagnosis at Lankenau Medical Center. The verdict is the largest so far this year in Philadelphia. A Philadelphia jury reached $35 million verdict last week against Main Line...
Indica Labs’ HALO AP Dx digital pathology platform for primary diagnostics has received FDA 510(k) clearance with Leica Biosystems’ Aperio GT 450 DX Scanner and is cleared for use with both SVS and DICOM file formats. ALBUQUERQUE, NM,...
Proscia Achieves SOC 2 Type II Certification, Strengthening Enterpr...
Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale PHILADELPHIA – December 3, 2025 – Proscia®, a pathology AI company, has successfully completed its SOC 2 Type II audit....
